Show simple item record

dc.contributor.authorFabian, Juneen
dc.contributor.authorMaher, Heather Anneen
dc.contributor.authorClark, Chevonen
dc.contributor.authorNaicker, Saraladevien
dc.contributor.authorBecker, Pieten
dc.contributor.authorVenter, Willem Daniel Francoisen
dc.date.accessioned2016-01-28T10:39:08Zen
dc.date.available2016-01-28T10:39:08Zen
dc.date.issued2015-02en
dc.identifier.citationMorbidity and mortality of black HIV-positive patients with end-stage kidney disease receiving chronic haemodialysis in South Africa. 2015, 105 (2):110-4 S. Afr. Med. J.en
dc.identifier.issn0256-9574en
dc.identifier.pmid26242528en
dc.identifier.urihttp://hdl.handle.net/11288/595143en
dc.description.abstractINTRODUCTION: There are few published data from South Africa (SA) on the outcomes of black HIV-positive patients receiving chronic haemodialysis. METHODS: This retrospective study compared the incidences of vascular and infectious morbidity and mortality in black HIV-positive patients with those in a group of HIV-negative patients matched for ethnicity, age and gender. All the patients were receiving chronic haemodialysis in the medically insured healthcare sector of SA. RESULTS: The incidence of tuberculosis and hospital admission rates for vascular access-related infections were significantly higher in the HIV-positive group than the HIV-negative group. The HIV-positive group had significantly lower albumin (p<0.05) and haemoglobin levels (p<0.01), but this did not impact on mortality. Survival in both groups was excellent. In the HIV-positive group, viral suppression rates were suboptimal with <50% of patients on antiretroviral therapy completely virally suppressed. CONCLUSION: This study has shown that black HIV-positive patients receiving chronic haemodialysis in a healthcare-funded environment in SA have excellent overall survival in spite of higher hospital admission rates and higher infectious morbidity compared with HIV-negative patientsen
dc.description.sponsorshipUnrestricted research grants from NRC, SA, and Roche, SA. WDFV is supported by PEPFAR.en
dc.language.isoenen
dc.relation.urlhttp://www.scielo.org.za/scielo.php?pid=S0256-95742015000200019&script=sci_arttexten
dc.subjectMorbidityen
dc.subjectmortalityen
dc.subjectHIV-positiveen
dc.subjectkidney diseaseen
dc.subjectSouth Africaen
dc.subjectchronic haemodialysisen
dc.subjectend-stageen
dc.titleMorbidity and mortality of black HIV-positive patients with end-stage kidney disease receiving chronic haemodialysis in South Africa.en
dc.typeArticleen
dc.identifier.journalSouth African Medical Journalen
dc.research.unitBiostatistics Uniten
dc.date.epub2015-01-07en


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record